Amended Statement of Ownership (sc 13g/a)
February 16 2016 - 1:23PM
Edgar (US Regulatory)
|
|
|
|
UNITED
STATES |
|
|
SECURITIES
AND EXCHANGE COMMISSION |
|
|
Washington,
D.C. 20549 |
|
|
|
|
SCHEDULE
13G
Under
the Securities Exchange Act of 1934
(Amendment No. 11)*
Corcept
Therapeutics Incorporated |
(Name
of Issuer)
(Title
of Class of Securities)
(CUSIP
Number)
(Date
of Event Which Requires Filing of this Statement)
Check
the appropriate box to designate the rule pursuant to which this Schedule is filed:
☐ |
Rule 13d-1(b) |
☐ |
Rule 13d-1(c) |
☒ |
Rule 13d-1(d) |
*The
remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the
subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided
in a prior cover page.
The information
required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the
Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall
be subject to all other provisions of the Act (however, see the Notes).
CUSIP
No. 218352102 |
|
|
1. |
Names
of Reporting Persons.
Sutter Hill Ventures, a California Limited Partnership |
|
|
2. |
Check the Appropriate Box if a
Member of a Group (See Instructions) |
|
|
(a) |
☐ |
|
|
(b) |
☒ |
|
|
3. |
SEC
Use Only |
|
|
4. |
Citizenship
or Place of Organization
California, USA |
|
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With |
5. |
Sole
Voting Power
-0- |
|
6. |
Shared
Voting Power
-0- |
|
7. |
Sole
Dispositive Power
-0- |
|
8. |
Shared
Dispositive Power
-0- |
|
|
9. |
Aggregate
Amount Beneficially Owned by Each Reporting Person
-0- |
|
|
10. |
Check
if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ☐ |
|
|
11. |
Percent
of Class Represented by Amount in Row (9)
0% |
|
|
12. |
Type
of Reporting Person (See Instructions)
PN |
|
|
|
|
|
|
CUSIP
No. 218352102 |
|
|
1. |
Names
of Reporting Persons.
G. Leonard Baker, Jr. |
|
|
2. |
Check the Appropriate Box if a
Member of a Group (See Instructions) |
|
|
(a) |
☐ |
|
|
(b) |
☒ |
|
|
3. |
SEC
Use Only |
|
|
4. |
Citizenship
or Place of Organization
USA |
|
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With |
5. |
Sole
Voting Power
4,505,527* |
|
6. |
Shared
Voting Power
-0- |
|
7. |
Sole
Dispositive Power
4,505,527* |
|
8. |
Shared
Dispositive Power
-0- |
|
|
9. |
Aggregate
Amount Beneficially Owned by Each Reporting Person
4,505,527 |
|
|
10. |
Check
if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ☐ |
|
|
11. |
Percent
of Class Represented by Amount in Row (9)
4.1% |
|
|
12. |
Type
of Reporting Person (See Instructions)
IN |
|
|
|
|
|
|
* See
Appendix A, Note 1
CUSIP
No. 218352102 |
|
|
1. |
Names
of Reporting Persons.
Tench Coxe |
|
|
2. |
Check the Appropriate Box if a
Member of a Group (See Instructions) |
|
|
(a) |
☐ |
|
|
(b) |
☒ |
|
|
3. |
SEC
Use Only |
|
|
4. |
Citizenship
or Place of Organization
USA |
|
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With |
5. |
Sole
Voting Power
1,696,051* |
|
6. |
Shared
Voting Power
-0- |
|
7. |
Sole
Dispositive Power
1,696,051* |
|
8. |
Shared
Dispositive Power
-0- |
|
|
9. |
Aggregate
Amount Beneficially Owned by Each Reporting Person
1,696,051 |
|
|
10. |
Check
if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ☐ |
|
|
11. |
Percent
of Class Represented by Amount in Row (9)
1.6% |
|
|
12. |
Type
of Reporting Person (See Instructions)
IN |
|
|
|
|
|
|
* See
Appendix A, Note 2.
CUSIP
No. 218352102 |
|
|
1. |
Names
of Reporting Persons.
James N. White |
|
|
2. |
Check the Appropriate Box if a
Member of a Group (See Instructions) |
|
|
(a) |
☐ |
|
|
(b) |
☒ |
|
|
3. |
SEC
Use Only |
|
|
4. |
Citizenship
or Place of Organization
USA |
|
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With |
5. |
Sole
Voting Power
393,520* |
|
6. |
Shared
Voting Power
-0- |
|
7. |
Sole
Dispositive Power
393,520* |
|
8. |
Shared
Dispositive Power
-0- |
|
|
9. |
Aggregate
Amount Beneficially Owned by Each Reporting Person
393,520 |
|
|
10. |
Check
if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ☐ |
|
|
11. |
Percent
of Class Represented by Amount in Row (9)
0.4% |
|
|
12. |
Type
of Reporting Person (See Instructions)
IN |
|
|
|
|
|
|
* See
Appendix A, Note 3.
CUSIP No. 218352102 |
|
|
1. |
Names of Reporting Persons.
Jeffrey W. Bird |
|
|
2. |
Check the Appropriate Box if a Member of a Group (See Instructions) |
|
|
(a) |
o |
|
|
(b) |
x |
|
|
3. |
SEC Use Only |
|
|
4. |
Citizenship or Place of Organization
USA |
|
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With |
5. |
Sole Voting Power
381,442* |
|
6. |
Shared Voting Power
-0- |
|
7. |
Sole Dispositive Power
381,442* |
|
8. |
Shared Dispositive Power
-0- |
|
|
9. |
Aggregate Amount Beneficially Owned by Each Reporting Person
381,442 |
|
|
10. |
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) o |
|
|
11. |
Percent of Class Represented by Amount in Row (9)
0.4% |
|
|
12. |
Type of Reporting Person (See Instructions)
IN |
|
|
|
|
|
|
* See Appendix A, Note 4.
CUSIP No. 218352102 |
|
|
1. |
Names of Reporting Persons.
Michael L. Speiser |
|
|
2. |
Check the Appropriate Box if a Member of a Group (See Instructions) |
|
|
(a) |
o |
|
|
(b) |
x |
|
|
3. |
SEC Use Only |
|
|
4. |
Citizenship or Place of Organization
USA |
|
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With |
5. |
Sole Voting Power
372,515* |
|
6. |
Shared Voting Power
-0- |
|
7. |
Sole Dispositive Power
372,515* |
|
8. |
Shared Dispositive Power
-0- |
|
|
9. |
Aggregate Amount Beneficially Owned by Each Reporting Person
372,515 |
|
|
10. |
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) o |
|
|
11. |
Percent of Class Represented by Amount in Row (9)
0.3% |
|
|
12. |
Type of Reporting Person (See Instructions)
IN |
|
|
|
|
|
|
* See Appendix A, Note 5.
CUSIP No. 218352102 |
|
|
1. |
Names of Reporting Persons.
Stefan A. Dyckerhoff |
|
|
2. |
Check the Appropriate Box if a Member of a Group (See Instructions) |
|
|
(a) |
o |
|
|
(b) |
x |
|
|
3. |
SEC Use Only |
|
|
4. |
Citizenship or Place of Organization
German citizen (U.S. permanent resident) |
|
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With |
5. |
Sole Voting Power
41,062* |
|
6. |
Shared Voting Power
-0- |
|
7. |
Sole Dispositive Power
41,062* |
|
8. |
Shared Dispositive Power
-0- |
|
|
9. |
Aggregate Amount Beneficially Owned by Each Reporting Person
41,062 |
|
|
10. |
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) o |
|
|
11. |
Percent of Class Represented by Amount in Row (9)
0.0% |
|
|
12. |
Type of Reporting Person (See Instructions)
IN |
|
|
|
|
|
|
*
See Appendix A, Note 6.
CUSIP No. 218352102 |
|
|
1. |
Names of Reporting Persons.
Samuel J. Pullara III |
|
|
2. |
Check the Appropriate Box if a Member of a Group (See Instructions) |
|
|
(a) |
o |
|
|
(b) |
x |
|
|
3. |
SEC Use Only |
|
|
4. |
Citizenship or Place of Organization
USA |
|
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With |
5. |
Sole Voting Power
41,062* |
|
6. |
Shared Voting Power
-0- |
|
7. |
Sole Dispositive Power
41,062* |
|
8. |
Shared Dispositive Power
-0- |
|
|
9. |
Aggregate Amount Beneficially Owned by Each Reporting Person
41,062 |
|
|
10. |
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) o |
|
|
11. |
Percent of Class Represented by Amount in Row (9)
0.0% |
|
|
12. |
Type of Reporting Person (See Instructions)
IN |
|
|
|
|
|
|
*
See Appendix A, Note 7.
Item 1. |
|
|
(a) |
Name of Issuer
Corcept Therapeutics Incorporated |
|
(b) |
Address of Issuer’s Principal Executive Offices
149 Commonwealth Drive, Menlo Park, CA 94025 |
|
Item 2. |
|
|
(a) |
Name of Person Filing
See Appendix A; Appendix A is hereby incorporated by reference |
|
(b) |
Address of Principal Business Office or, if none, Residence
See Appendix A |
|
(c) |
Citizenship
See Appendix A |
|
(d) |
Title of Class of Securities
Common Stock |
|
(e) |
CUSIP Number
218352102 |
|
Item 3. |
If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: |
|
|
|
(a) |
☐ |
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). |
|
|
|
|
|
(b) |
☐ |
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). |
|
|
|
|
|
(c) |
☐ |
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). |
|
|
|
|
|
(d) |
☐ |
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). |
|
|
|
|
|
(e) |
☐ |
An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E); |
|
|
|
|
|
(f) |
☐ |
An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F); |
|
|
|
|
|
(g) |
☐ |
A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G); |
|
|
|
|
|
(h) |
☐ |
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); |
|
|
|
|
|
(i) |
☐ |
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); |
|
|
|
|
|
(j) |
☐ |
Group, in accordance with §240.13d-1(b)(1)(ii)(J). |
|
|
|
|
|
|
☒ |
N/A |
Item 4. |
Ownership |
|
|
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. |
|
|
(a) |
Amount beneficially owned:
See Appendix A, which is hereby incorporated by reference
and related pages 2 to 9 |
|
(b) |
Percent of class:
See Appendix A, which is hereby incorporated by reference
and related pages 2 to 9 |
|
(c) |
Number of shares as to which the person has:
|
|
|
(i) |
Sole power to vote or to direct the vote
*** |
|
|
(ii) |
Shared power to vote or to direct the vote
*** |
|
|
(iii) |
Sole power to dispose or to direct the disposition
of
*** |
|
|
(iv) |
Shared power to dispose or to direct the disposition
of
*** |
***
See Appendix A, which is hereby incorporated by reference and related pages 2 to 9. Mr. Baker is a managing director and together
with Messrs. Coxe, White, Bird, Speiser, Dyckerhoff and Pullara who are also managing directors and members of the management
committee of the general partner of Sutter Hill Ventures, a California Limited Partnership share voting and dispositive power
over the shares held by the partnership.
Item 5. |
Ownership of Five Percent or Less of a Class |
|
|
If this statement is being filed to report the fact that as of the date hereof
the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the
following ☒. |
|
Item 6. |
Ownership of More than Five Percent on Behalf of Another Person |
|
|
N/A |
|
Item 7. |
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person |
|
|
N/A |
|
Item 8. |
Identification and Classification of Members of the Group |
|
|
See Appendix A |
|
Item 9. |
Notice of Dissolution of Group |
|
|
N/A |
|
Item 10. |
Certification |
|
|
N/A |
Signature
After
reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement
is true, complete and correct.
|
2/16/2016 |
|
Date |
|
|
|
Sutter Hill Ventures, A California Limited
Partnership |
|
|
|
/s/
Robert Yin |
|
Robert Yin, Attorney-in-Fact for G.
Leonard Baker, Jr., Managing Director of the General Partner |
|
|
|
/s/
Robert Yin |
|
Robert Yin, Attorney-in-Fact for G.
Leonard Baker, Jr. |
|
|
|
/s/
Robert Yin |
|
Robert
Yin, Attorney-in-Fact for Tench Coxe
|
|
/s/
Robert Yin |
|
Robert Yin, Attorney-in-Fact for James
N. White |
|
|
|
/s/
Robert Yin |
|
Robert
Yin, Attorney-in-Fact for Jeffrey W. Bird
|
|
/s/
Robert Yin |
|
Robert Yin, Attorney-in-Fact for Michael
L. Speiser |
|
|
|
/s/
Robert Yin |
|
Robert Yin, Attorney-in-Fact for Stefan
A. Dyckerhoff |
|
|
|
/s/
Robert Yin |
|
Robert Yin, Attorney-in-Fact for Samuel
J. Pullara III |
APPENDIX A
TO SCHEDULE 13G — CORCEPT THERAPEUTICS INCORPORATED
|
|
Aggregate Number of |
|
|
|
|
|
Shares Beneficially Owned |
|
% of |
|
Name of Originator |
|
Individual |
|
|
|
Aggregate |
|
Total Shares |
|
|
|
|
|
|
|
|
|
|
|
Sutter Hill Ventures,
a California Limited Partnership |
|
-0- |
|
|
|
|
|
0.0 |
% |
|
|
|
|
|
|
|
|
|
|
G. Leonard Baker, Jr. |
|
4,505,527 |
|
Note 1 |
|
|
|
4.1 |
% |
|
|
|
|
|
|
4,505,527 |
|
4.1 |
% |
|
|
|
|
|
|
|
|
|
|
Tench Coxe |
|
1,696,051 |
|
Note 2 |
|
|
|
1.6 |
% |
|
|
|
|
|
|
1,696,051 |
|
1.6 |
% |
|
|
|
|
|
|
|
|
|
|
James N. White |
|
393,520 |
|
Note 3 |
|
|
|
0.4 |
% |
|
|
|
|
|
|
393,520 |
|
0.4 |
% |
|
|
|
|
|
|
|
|
|
|
Jeffrey W. Bird |
|
381,442 |
|
Note 4 |
|
|
|
0.4 |
% |
|
|
|
|
|
|
381,442 |
|
0.4 |
% |
|
|
|
|
|
|
|
|
|
|
Michael L. Speiser |
|
372,515 |
|
Note 5 |
|
|
|
0.3 |
% |
|
|
|
|
|
|
372,515 |
|
0.3 |
% |
|
|
|
|
|
|
|
|
|
|
Stefan A. Dyckerhoff |
|
41,062 |
|
Note 6 |
|
|
|
0.0 |
% |
|
|
|
|
|
|
41,062 |
|
0.0 |
% |
|
|
|
|
|
|
|
|
|
|
Samuel J. Pullara
III |
|
41,062 |
|
Note 7 |
|
|
|
0.0 |
% |
|
|
|
|
|
|
41,062 |
|
0.0 |
% |
The
address for all of the above is: 755 Page Mill Road, Suite A-200, Palo Alto, CA 94304.
The
partnerships are organized in California. The individuals are all U.S. citizens and residents with the exception of Mr. Dyckerhoff
who is a citizen of Germany and U.S. permanent resident.
None
of the above has been convicted in any criminal proceedings nor have they been subject to judgments, decrees, or final orders
enjoining future violations of Federal or State securities laws.
All
of the parties are individuals or entities in the venture capital business.
Note
1: Comprised of 207 shares held in the individual’s name, 955,055 shares held in The Baker Revocable Trust of which the
reporting person is a trustee, 676,631 shares held by a Roth IRA for the benefit of the reporting person, 2,613,634 shares held
by Saunders Holdings, L.P. of which the reporting person is a trustee of a trust which is the general partner and 260,000 shares
of director’s options that are fully vested and exercisable within 60 days after 12/31/15.
Note
2: Comprised of 454,214 shares held in The Coxe Revocable Trust of which the reporting person is a trustee, 581,514 shares held
by a retirement trust for the benefit of the reporting person, 572,519 shares held by Rooster Partners, L.P. of which the reporting
person is a trustee of a trust which is the general partner and 87,804 shares held in The Tamerlane Charitable Remainder Unitrust
of which the reporting person is the trustee.
Note
3: Comprised of 373,361 shares held in The White Revocable Trust of which the reporting person is a trustee, 1,073 shares held
by a retirement trust for the benefit of the reporting person and 19,086 shares held by a Roth IRA for the benefit of the reporting
person.
Note
4: Comprised of 381,442 shares held in the Jeffrey W. and Christina R. Bird Trust of which the reporting person is a trustee.
Note
5: Comprised of 372,515 shares held in the Speiser Trust of which the reporting person is a trustee.
Note
6: Comprised of 41,062 shares held in the Dyckerhoff 2001 Revocable Trust of which the reporting person is a trustee.
Note
7: Comprised of 41,062 shares held in The Pullara Revocable Trust of which the reporting person is a trustee.
Corcept Therapeutics (NASDAQ:CORT)
Historical Stock Chart
From Apr 2024 to May 2024
Corcept Therapeutics (NASDAQ:CORT)
Historical Stock Chart
From May 2023 to May 2024